Request a Quote |
In vitro Toxicology

ATP Content in 3D Microtissues

Background information

  • The environment created by a 3D culture model allows reconstitution of the natural cellular physiology by promoting the complex cell-cell and cell-matrix network communications found in vivo.
  • Different scaffold-free 3D microtissue models are available at Cyprotex including spheroids produced using Ultra-low adhesion plates or using hanging drop technology.
  • Microtissues can be formed from single or co-cultured cell populations and their longevity permits use in long-term repeat dose toxicity studies to investigate any cumulative effect.
  • ATP content is a biochemical endpoint used to measure general cell viability. This can be incorporated with LDH release to monitor cell death over time.


ATP content in 3D microtissues

Microtissues* HepaRG, liver, spontaneously beating cardiac (mono-and co-cultures available)
Endpoints* ATP content, LDH release**
Time Points* 4 hr, 16 hr, 72 hr and 14 day repeat dose

*others available on request
**HCS imaging service to monitor GSH content, ROS formation, phospholipidosis, steatosis, mitochondrial membrane potential also available with the Ultra low adhesion model. Find out more.


Data from ATP content in 3D microtissues assay

Figure 1
Determination of cellular ATP levels using Promega’s CellTiter Glo® luminescent cell viability assay, following exposure of 3D microtissues to rosiglitazone.
Get a Quote
Product sheet ADME Guide DDI Guide TOX Guide

Contact us to discuss your ADME Tox issues or request a quote

North America (East Coast): +1-888-297-7683
Europe: +44 (0)1625 5051000


or fill out the form below:

Please give details of the assays you are interested in. Where appropriate please specify one or more species (human, rat, mouse etc.), isoforms (CYP1A1,CYP1B1, etc) or other relevant details.

By clicking on ‘Send’ I agree that my data is being transferred and used by Cyprotex and the affiliated Evotec Group. The Evotec Group currently consists of the following companies. For further details please see our privacy policy.

If you would like to be kept informed of our latest services, new research, events and other news please tick the box below: